dollar at the applicable foreign exchange rates in effect during the comparable prior-year period. Reconciliation of Net Sales to Net Sales at Constant Currency(1) (1) Net sales at constant currency translates the current-period reported sales of subsidiaries whose functional currency is other than the U.S. Verux Brand and the logo are trademarks of West Pharmaceutical Services Singapore Pte. Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd. or its subsidiaries, in the United States and other jurisdictions, unless noted otherwise. Trademarks Registered trademarks used in this report are the property of West Pharmaceutical Services, Inc. Please refer to “Reconciliation of Non-GAAP Measures” at the end of these materials for more information. Non-GAAP financial measures should not be considered in isolation or as an alternative to such measures determined in accordance with GAAP. GAAP”), and therefore are referred to as non- GAAP financial measures.
generally accepted accounting principles (“U.S. GAAP Financial Measures Certain financial measures included in these presentation materials, or which may be referred to in management’s discussion of the Company’s results and outlook, have not been calculated in accordance with U.S.
Lg cd rom drive gcr 8238 update#
Except as required by law or regulation, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise. You should evaluate any statement in light of these important factors. We caution investors that the risk factors listed under “Cautionary Statement” in our press releases, as well as those set forth under the caption "Risk Factors" in our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission and as revised or supplemented by our quarterly reports on Form 10-Q, could cause our actual results to differ materially from those estimated or predicted in the forward-looking statements. Each of these statements is based on preliminary information, and actual results could differ from any preliminary estimates. Such statements include, but are not limited to, statements about product development and operational performance.
Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This slide presentation and any accompanying management commentary contain “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995.
0 kommentar(er)
